GeneCopoeia’s BlazeTaq™ Probe One-Step SARS-CoV-2 Detection Kit is a next-generation solution designed for highly sensitive and accurate detection of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. This RT-qPCR-based kit, which uses hydrolysis probe technology similar to TaqMan®, is newly designed from the ground up with primers that detect the S (Spike) and N (nucleocapsid) genes of multiple strains of SARS-CoV-2.
The BlazeTaq™ Probe One-Step SARS-CoV-2 Detection Kit is part of GeneCopoeia’s COVID-19 Coronavirus Research Tools product line.
Advantages
- High sensitivity. Can detect as few as 10 copies of the viral target sequences.
- Shorter reaction times. Uses GeneCopoeia’s BlazeTaq™ antibody-modified polymerase, which results in a faster hot start.
- Broad-spectrum detection. Proprietary primer/probe designs enable detection of most SARS-CoV-2 strains.
- Specificity. Inclusion of UDG and dUTP in the reaction reduces carryover contamination, resulting in fewer false positives.
- Convenient. All required reagents are included in the kit, enabling one-step processing of samples to final data.
- Instrument compatibility. Optional ROX dye ensures compatibility with virtually all qPCR instruments in use.
Note: The BlazeTaq™ Probe One-Step SARS-CoV-2 Detection Kit is for research purposes only. It is not intended for diagnostic or treatment usage in humans.
For more information or to request a quote, please contact inquiry@genecopoeia.com.
Performance data
Performance data
Figure 1. Performance of the BlazeTaq™ Probe One-Step SARS-CoV-2 Detection Kit. A. Cycle curves plotted against relative fluorescence units (RFU). B. Ct values for ten-fold serial dilutions of the positive control template. S: Spike gene. N: Nucleocapsid gene. GAPDH: Human reference gene. NTC: No template control. N/A: No amplification. Reactions were performed in duplicate.
A |
B |
 |
 |